BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29153461)

  • 1. Population-based Borrelia burgdorferi sensu lato seroprevalence and associated risk factors in Finland.
    van Beek J; Sajanti E; Helve O; Ollgren J; Virtanen MJ; Rissanen H; Lyytikäinen O; Hytönen J; Sane J
    Ticks Tick Borne Dis; 2018 Feb; 9(2):275-280. PubMed ID: 29153461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of Lyme borreliosis in Finland 50 years ago.
    Cuellar J; Dub T; Sane J; Hytönen J
    Clin Microbiol Infect; 2020 May; 26(5):632-636. PubMed ID: 31622667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradigm Burgenland: risk of Borrelia burgdorferi sensu lato infection indicated by variable seroprevalence rates in hunters.
    Cetin E; Sotoudeh M; Auer H; Stanek G
    Wien Klin Wochenschr; 2006 Nov; 118(21-22):677-81. PubMed ID: 17160606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood donor Borrelia burgdorferi sensu lato seroprevalence and history of tick bites at a northern limit of the vector distribution.
    Hvidsten D; Mortensen L; Straume B; Arsenovic MG; Pedersen AB; Lyngås G; Gray JS; Grude N
    APMIS; 2017 Aug; 125(8):717-724. PubMed ID: 28612350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence for
    Septfons A; Rigaud E; Bénézet L; Velay A; Zilliox L; Baldinger L; Gonzalez G; Figoni J; de Valk H; Deffontaines G; Desenclos JC; Jaulhac B
    Euro Surveill; 2023 Aug; 28(32):. PubMed ID: 37561054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of antibodies against Borrelia burgdorferi sensu lato in healthy blood donors in Romania: an update.
    Kalmár Z; Briciu V; Coroian M; Flonta M; Rădulescu AL; Topan A; Mihalca AD; Lupșe M
    Parasit Vectors; 2021 Dec; 14(1):596. PubMed ID: 34863277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of heart failure among individuals tested for Borrelia burgdorferi sensu lato antibodies, and serum Borrelia burgdorferi sensu lato seropositive individuals; a nationwide population-based, registry-based matched cohort study.
    Tetens MM; Omland LH; Dessau RB; Ellermann-Eriksen S; Andersen NS; Jørgensen CS; Østergaard C; Bodilsen J; Søgaard KK; Bangsborg J; Nielsen ACY; Møller JK; Chen M; Svendsen JH; Obel N; Lebech AM
    Ticks Tick Borne Dis; 2024 Jul; 15(4):102345. PubMed ID: 38636178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG seroprevalence of Lyme borreliosis in the population of the Aland Islands in Finland.
    Carlsson SA; Granlund H; Nyman D; Wahlberg P
    Scand J Infect Dis; 1998; 30(5):501-3. PubMed ID: 10066053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of Lyme disease in Eastern Slovakia.
    Bušová A; Dorko E; Rimárová K; Diabelková J; Rovenská T; Feketeová E; Bereš M; Čellár R; Baranová Z; Kampe T; Benhatchi K
    Cent Eur J Public Health; 2018 Dec; 26 Suppl():S67-S71. PubMed ID: 30817877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seropositivity of Lyme borreliosis and associated risk factors: a population-based study in Children and Adolescents in Germany (KiGGS).
    Dehnert M; Fingerle V; Klier C; Talaska T; Schlaud M; Krause G; Wilking H; Poggensee G
    PLoS One; 2012; 7(8):e41321. PubMed ID: 22905101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study on the incidence of Borrelia burgdorferi sensu lato infection after a tick bite in Sweden and on the Åland Islands, Finland (2008-2009).
    Wilhelmsson P; Fryland L; Lindblom P; Sjöwall J; Ahlm C; Berglund J; Haglund M; Henningsson AJ; Nolskog P; Nordberg M; Nyberg C; Ornstein K; Nyman D; Ekerfelt C; Forsberg P; Lindgren PE
    Ticks Tick Borne Dis; 2016 Feb; 7(1):71-79. PubMed ID: 26341726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographical differences in seroprevalence of Borrelia burgdorferi antibodies in Norway, 2011-2013.
    Vestrheim DF; White RA; Aaberge IS; Aase A
    Ticks Tick Borne Dis; 2016 Jul; 7(5):698-702. PubMed ID: 26961275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of Lyme disease and genospecies of Borrelia burgdorferi sensu lato in patients diagnosed with borreliosis in the Province of Warmia-Masuria in north-eastern Poland.
    Kubiak K; Dzika E; Równiak J; Dziedziech M; Dzisko J
    Ann Agric Environ Med; 2012; 19(2):203-7. PubMed ID: 22742788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic survey of the wild boar (Sus scrofa) for Borrelia burgdorferi sensu lato.
    Juricová Z; Hubálek Z
    Vector Borne Zoonotic Dis; 2009 Oct; 9(5):479-82. PubMed ID: 18973452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of tests for detection of Borrelia burgdorferi sensu lato infection in patients with diagnosed borreliosis.
    Chmielewska-Badora J; Cisak E; Wójcik-Fatla A; Zwoliński J; Buczek A; Dutkiewicz J
    Ann Agric Environ Med; 2006; 13(2):307-11. PubMed ID: 17196006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological evidence of Borrelia burgdorferi sensu lato in horses and cattle from Poland and diagnostic problems of Lyme borreliosis.
    Stefanciková A; Adaszek Ł; Pet'ko B; Winiarczyk S; Dudinák V
    Ann Agric Environ Med; 2008; 15(1):37-43. PubMed ID: 18581977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence, spatial distribution and risk factors of Borrelia burgdorferi sensu lato in Jordan.
    Obaidat MM; Alshehabat MA; Hayajneh WA; Roess AA
    Comp Immunol Microbiol Infect Dis; 2020 Dec; 73():101559. PubMed ID: 33086189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and incidence of antibodies to Borrelia burgdorferi and to tick-borne encephalitis virus in agricultural and forestry workers from Tuscany, Italy.
    Tomao P; Ciceroni L; D'Ovidio MC; De Rosa M; Vonesch N; Iavicoli S; Signorini S; Ciarrocchi S; Ciufolini MG; Fiorentini C; Papaleo B
    Eur J Clin Microbiol Infect Dis; 2005 Jul; 24(7):457-63. PubMed ID: 15948001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of Borrelia burgdorferi in Belgian forestry workers and associated risk factors.
    De Keukeleire M; Robert A; Luyasu V; Kabamba B; Vanwambeke SO
    Parasit Vectors; 2018 May; 11(1):277. PubMed ID: 29716647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.
    Lernout T; Kabamba-Mukadi B; Saegeman V; Tré-Hardy M; de Laveleye M; Asikainen T; Dessau RB; Quoilin S; Litzroth A
    BMC Public Health; 2019 May; 19(1):597. PubMed ID: 31101034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.